Blood glucose level and survival in streptozotocin-treated human chymase transgenic mice

Chinese Journal of Physiology

Volumn 54, Issue 1, 2011, Pages 30-35

  Rafiq, Kazi ^a   Sherajee, Shamshad J ^a   Fan, Yu Yan ^a   Fujisawa, Yoshihide ^b   Takahashi, Yoshimasa ^c   Matsuura, Junji ^c   Hase, Naoki ^c   Urata, Hidenori ^d   Nakano, Daisuke ^a   Hitomi, Hirofumi ^a   Nishiyama, Akira ^a  

^a Department of Pharmacology ^*  (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c TEIJIN PHARMA LIMITED   (Japan)

^d Fukuoka University Chikushi Hospital   (Japan)

Author keywords

Diabetes; Human chymase transgenic mice; Streptozotocin; Survival

Indexed keywords

CHYMASE; GLUCOSE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; GLUCOSE BLOOD LEVEL; HEART RATE VARIABILITY; HETEROZYGOTE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; POSTPRANDIAL STATE; STRAIN DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE; TRANSGENIC MOUSE; WILD TYPE;

EID: 79955490484     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2011.AMM008     Document Type: Article

References (25)

1. Cristovam, P.C., Arnoni, C.P., de Andrade, M.C., Casarini, D.E., Pereira, L.G., Schor, N. and Boim, M.A. ACE-dependent and chymase-dependent angiotensin II generation in normal and glucose-stimulated human mesangial cells. Exp. Biol. Med. (Maywood) 233: 1035-1043, 2008.
2. Dell'Italia, L.J. and Husain, A. Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases. Curr. Opin. Cardiol. 17: 374-379, 2002.
3. He, S., Peng, Q. and Walls, A.F. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine. J. Immunol. 159: 6216-6225, 1997.
4. Hoffmann, S., Krause, T., van Geel, P.P., Willenbrock, R., Pagel, I., Pinto, Y.M., Buikema, H., van Gilst, W.H., Lindschau, C., Paul, M., Inagami, T., Ganten, D. and Urata, H. Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy. J. Mol. Med. 79: 601-608, 2001.
5. Huang, X.R., Chen, W.Y., Truong, L.D. and Lan, H.Y. Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease. J. Am. Soc. Nephrol. 14: 1738-1747, 2003.
6. Ju, H., Gros, R., You, X., Tsang, S., Husain, M. and Rabinovitch, M. Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 98: 7469-7474, 2001.
7. Koga, T., Urata, H., Inoue, Y., Hoshino, T., Okamoto, T., Matsunaga, A., Suzuki, M., Miyazaki, J., Ideishi, M., Arakawa, K. and Saku, K. Human chymase expression in a mice induces mild hypertension with left ventricular hypertrophy. Hypertens. Res. 26: 759-768, 2003.
8. Koka, V., Wang, W., Huang, X.R., Kim-Mitsuyama, S., Truong, L.D. and Lan, H.Y. Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications. Circulation 113: 1353-1360, 2006.
9. Lattanand, A. and Johnson, W.C. Male pattern alopecia a histopathologic and histochemical study. J. Cutan. Pathol. 2: 58-70, 1975.
10. Lavrentyev, E.N., Estes, A.M. and Malik, K.U. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells. Circ. Res. 101: 455-464, 2007.
11. Lewis, E.J., Hunsicker, L.G., Bain, R.P. and Rohde, R.D. for The Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329: 1456-1462, 1993.
12. Lewis, E.J., Hunsicker, L.G., Clarke, W.R., Berl, T., Pohl, M.A., Lewis, J.B., Ritz, E., Atkins, R.C., Rohde, R. and Raz, I. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345: 851-860, 2001.
13. Miyazaki, J., Takaki, S., Araki, K., Tashiro, F., Tominaga, A., Takatsu, K. and Yamamura, K. Expression vector system based on the chicken β-actin promoter directs efficient production of interleukin-5. Gene 79: 269-277, 1989.
14. Miyazaki, M. and Takai, S. Local angiotensin II-generating system in vascular tissues: the roles of chymase. Hypertens. Res. 24: 189-193, 2001.
15. Mizutani, H., Schechter, N., Lazarus, G., Black, R.A. and Kupper, T.S. Rapid and specific conversion of precursor interleukin 1 β (IL-1 β) to an active IL-1 species by human mast cell chymase. J. Exp. Med. 174: 821-825, 1991.
16. Parving, H.H., Lehnert, H., Brochner-Mortensen, J., Gomis, R., Andersen, S. and Arner, P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N. Engl. J. Med. 345: 870-878, 2001.
17. Pechhold, K., Patterson, N.B., Blum, C., Fleischacker, C.L., Boehm, B.O. and Harlan, D.M. Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigenspecific and CD28 dependent. J. Immunol. 166: 2531-2539, 2001.
18. Petrie, M.C., Padmanabhan, N., McDonald, J.E., Hillier, C., Connell, J.M. and McMurray, J.J. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. J. Am. Coll. Cardiol. 37: 1056-1061, 2001.
19. Reed, R.J., Clark, W.H. and Mihm, M.C. The cutaneous mucinoses. Hum. Pathol. 4: 201-205, 1973.
20. Rook, A.H., Prystowsky, M.B., Cassin, M., Boufal, M. and Lessin, S.R. Combined therapy for Sezary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy. Clinical, molecular, and immunologic observations. Arch. Dermatol. 127: 1535-1540, 1991.
21. Shimano, H., Yamada, N., Shimada, M., Ohsawa, N., Fukazawa, C., Yazaki, Y., Takaku, F. and Katsuki, M. Hepatic and renal expression of rat apolipoprotein E under control of the metallothionein promoter in transgenic mice. Biochim. Biophys. Acta. 1090: 91-94, 1991.
22. Szkudelski, T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 50: 537-546, 2001.
23. Takai, S., Jin, D., Ohzu, M., Tanaka, K. and Miyazaki, M. Chymase inhibition provides pancreatic islet protection in hamsters with streptozotocin-induced diabetes. J. Pharmacol. Sci. 110: 459-465, 2009.
24. Tunon de Lara, J.M., Okayama, Y., McEuen, A.R., Heusser, C.H., Church, M.K. and Walls, A.F. Release and inactivation of interleukin-4 by mast cells. Ann. N. Y. Acad. Sci. 725: 50-58, 1994.
25. Urata, H., Kinoshita, A., Perez, D.M., Misono, K.S., Bumpus, F.M., Graham, R.M. and Husain, A. Cloning of the gene and cDNA for human heart chymase. J. Biol. Chem. 266: 17173-17179, 1991.